Clinical trial
Lapatinib in Combination With Radiation Therapy in Patients With Brain…
NCT00470847 · Nancy Lin, MD, Other · Completed
Key facts
| NCT number | NCT00470847 |
|---|---|
| Title | Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer |
| Official title | A Phase I Study of Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer |
| Lead sponsor | Nancy Lin, MD, Other |
| Collaborators | Brigham and Women's Hospital Breast Cancer Research Foundation GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Brain Metastases |
| Intervention type | Drug, Procedure |
| Interventions | Lapatinib, Whole Brain Radiation, Herceptin |
| Enrollment | 35 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Jun 1, 2012 |
| First posted | May 8, 2007 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: